Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: "Efficacy and Safety of Linaclotide in Chronic Constipation" [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of linaclotide for chronic constipation is not yet recruiting. The study sponsor is Md Mehedi Shahriar.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linzess (linaclotide)

Snippet

Sponsor: Md Mehedi Shahriar | Conditions: Chronic Idiopathic Constipation, Irritable Bowel Syndrome (IBS-C) | Phase 4 | Status: NOT_YET_RECRUITING